NEW YORK (GenomeWeb) – Piper Jaffray today downgraded shares of Hologic to a Neutral rating, saying that it sees limited opportunity for the company's shares to grow in value.

In a research note, analyst William Quirk downgraded Hologic from a previous Overweight rating but said the fundamental turnaround thesis remains intact.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.